BLUE CAP AG (B7E.DE) Fundamental Analysis & Valuation

FRA:B7E • DE000A0JM2M1

Current stock price

17.5 EUR
0 (0%)
Last:

This B7E.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. B7E.DE Profitability Analysis

1.1 Basic Checks

  • B7E had positive earnings in the past year.
  • B7E had a positive operating cash flow in the past year.
  • B7E had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years B7E had a positive operating cash flow.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • With an excellent Return On Assets value of 9.48%, B7E belongs to the best of the industry, outperforming 88.60% of the companies in the same industry.
  • B7E has a better Return On Equity (20.25%) than 82.46% of its industry peers.
  • B7E has a better Return On Invested Capital (6.33%) than 72.81% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for B7E is below the industry average of 9.73%.
  • The 3 year average ROIC (5.02%) for B7E is below the current ROIC(6.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROIC 6.33%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • B7E's Profit Margin of 11.71% is in line compared to the rest of the industry. B7E outperforms 52.63% of its industry peers.
  • In the last couple of years the Profit Margin of B7E has grown nicely.
  • B7E has a Operating Margin (8.02%) which is in line with its industry peers.
  • B7E's Operating Margin has improved in the last couple of years.
  • The Gross Margin of B7E (49.70%) is better than 67.54% of its industry peers.
  • In the last couple of years the Gross Margin of B7E has grown nicely.
Industry RankSector Rank
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. B7E.DE Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for B7E remains at a similar level compared to 1 year ago.
  • B7E has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, B7E has an improved debt to assets ratio.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • B7E has an Altman-Z score of 2.18. This is not the best score and indicates that B7E is in the grey zone with still only limited risk for bankruptcy at the moment.
  • B7E has a Altman-Z score of 2.18. This is in the better half of the industry: B7E outperforms 71.05% of its industry peers.
  • B7E has a debt to FCF ratio of 4.61. This is a neutral value as B7E would need 4.61 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.61, B7E is in the better half of the industry, outperforming 76.32% of the companies in the same industry.
  • B7E has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • B7E has a Debt to Equity ratio of 0.32. This is in the better half of the industry: B7E outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Altman-Z 2.18
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • B7E has a Current Ratio of 1.73. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of B7E (1.73) is better than 75.44% of its industry peers.
  • A Quick Ratio of 1.39 indicates that B7E should not have too much problems paying its short term obligations.
  • B7E has a better Quick ratio (1.39) than 72.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.39
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. B7E.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 292.72% over the past year.
  • The Earnings Per Share has been growing by 33.00% on average over the past years. This is a very strong growth
  • B7E shows a decrease in Revenue. In the last year, the revenue decreased by -0.59%.
  • The Revenue has been decreasing by -1.79% on average over the past years.
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%

3.2 Future

  • Based on estimates for the next years, B7E will show a very negative growth in Earnings Per Share. The EPS will decrease by -55.87% on average per year.
  • The Revenue is expected to decrease by -5.75% on average over the next years.
EPS Next Y13.76%
EPS Next 2Y-88.67%
EPS Next 3Y-55.87%
EPS Next 5YN/A
Revenue Next Year-38.1%
Revenue Next 2Y-19.92%
Revenue Next 3Y-12.2%
Revenue Next 5Y-5.75%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. B7E.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 3.88, the valuation of B7E can be described as very cheap.
  • B7E's Price/Earnings ratio is rather cheap when compared to the industry. B7E is cheaper than 96.49% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.60, B7E is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 301.33, the valuation of B7E can be described as expensive.
  • B7E's Price/Forward Earnings ratio is in line with the industry average.
  • B7E's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.84.
Industry RankSector Rank
PE 3.88
Fwd PE 301.33
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, B7E is valued cheaply inside the industry as 96.49% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, B7E is valued cheaply inside the industry as 94.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.65
EV/EBITDA 2.96
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of B7E may justify a higher PE ratio.
  • A cheap valuation may be justified as B7E's earnings are expected to decrease with -55.87% in the coming years.
PEG (NY)0.28
PEG (5Y)0.12
EPS Next 2Y-88.67%
EPS Next 3Y-55.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. B7E.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.76%, B7E has a reasonable but not impressive dividend return.
  • B7E's Dividend Yield is a higher than the industry average which is at 3.30.
  • B7E's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 3.76%

5.2 History

  • The dividend of B7E decreases each year by -2.84%.
Dividend Growth(5Y)-2.84%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • The Dividend Rate of B7E has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-88.67%
EPS Next 3Y-55.87%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

B7E.DE Fundamentals: All Metrics, Ratios and Statistics

BLUE CAP AG

FRA:B7E (4/2/2026, 7:00:00 PM)

17.5

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-26
Earnings (Next)05-12
Inst Owners27.6%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap78.58M
Revenue(TTM)174.60M
Net Income(TTM)20.44M
Analysts82.5
Price Target30.55 (74.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.76%
Yearly Dividend0.65
Dividend Growth(5Y)-2.84%
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)80.73%
EPS NY rev (3m)80.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 3.88
Fwd PE 301.33
P/S 0.45
P/FCF 5.65
P/OCF 3.88
P/B 0.78
P/tB 1.49
EV/EBITDA 2.96
EPS(TTM)4.51
EY25.77%
EPS(NY)0.06
Fwd EY0.33%
FCF(TTM)3.1
FCFY17.71%
OCF(TTM)4.51
OCFY25.8%
SpS38.89
BVpS22.48
TBVpS11.77
PEG (NY)0.28
PEG (5Y)0.12
Graham Number47.76
Profitability
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROCE 9.09%
ROIC 6.33%
ROICexc 9.23%
ROICexgc 16.8%
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
FCFM 7.97%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
ROICexc(3y)6.63%
ROICexc(5y)7.25%
ROICexgc(3y)11.85%
ROICexgc(5y)10.59%
ROCE(3y)7.26%
ROCE(5y)7.8%
ROICexgc growth 3Y54.39%
ROICexgc growth 5Y35.47%
ROICexc growth 3Y30.62%
ROICexc growth 5Y18.26%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
F-Score8
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Debt/EBITDA 1.04
Cap/Depr 37.43%
Cap/Sales 3.64%
Interest Coverage 3.69
Cash Conversion 65.44%
Profit Quality 68.08%
Current Ratio 1.73
Quick Ratio 1.39
Altman-Z 2.18
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.83%
Cap/Depr(5y)33.96%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
EPS Next Y13.76%
EPS Next 2Y-88.67%
EPS Next 3Y-55.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%
Revenue Next Year-38.1%
Revenue Next 2Y-19.92%
Revenue Next 3Y-12.2%
Revenue Next 5Y-5.75%
EBIT growth 1Y224.21%
EBIT growth 3Y10.55%
EBIT growth 5Y14.76%
EBIT Next Year-25.67%
EBIT Next 3Y-21.89%
EBIT Next 5Y-14.12%
FCF growth 1Y-38.99%
FCF growth 3Y7.4%
FCF growth 5YN/A
OCF growth 1Y-27.35%
OCF growth 3Y1.47%
OCF growth 5Y47.8%

BLUE CAP AG / B7E.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLUE CAP AG (B7E.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to B7E.DE.


What is the valuation status of BLUE CAP AG (B7E.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to BLUE CAP AG (B7E.DE). This can be considered as Undervalued.


How profitable is BLUE CAP AG (B7E.DE) stock?

BLUE CAP AG (B7E.DE) has a profitability rating of 7 / 10.


What is the financial health of BLUE CAP AG (B7E.DE) stock?

The financial health rating of BLUE CAP AG (B7E.DE) is 5 / 10.


What is the expected EPS growth for BLUE CAP AG (B7E.DE) stock?

The Earnings per Share (EPS) of BLUE CAP AG (B7E.DE) is expected to grow by 13.76% in the next year.